logo
Select company
Select metric
$ -35.23MOperating Income
VS
Market
20
Sector
45
Industry
60
History
57
$ 1.65Close
$ 0.39 - $ 1.81 52-Week Range
Ticker Information

Ticker

LCTX

Company Name

LINEAGE CELL THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSEMKT

LINEAGE CELL THERAPEUTICS INC - Operating Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

LCTX - Op. Inc. Historical data
DateOperating Income
6/30/2025$ -35.23M
3/31/2025$ -21.32M
12/31/2024$ -21.48M
9/30/2024$ -22.73M
6/30/2024$ -25.59M
3/31/2024$ -24.75M
12/31/2023$ -24.73M
9/30/2023$ -25.01M
6/30/2023$ -23.56M
3/31/2023$ -22.77M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • LINEAGE CELL THERAPEUTICS INC's latest trailing twelve months (TTM) Op. Inc. stands at $ -27.44M.
  • Over the past 5 years, LINEAGE CELL THERAPEUTICS INC's average Op. Inc. has been $ -29.54M.
  • The median Op. Inc. for LINEAGE CELL THERAPEUTICS INC during this period was $ -25.83M
  • LINEAGE CELL THERAPEUTICS INC reached its highest Op. Inc. over the past 5 years at $ -21.32M.
  • The lowest Op. Inc. recorded by LINEAGE CELL THERAPEUTICS INC in the same timeframe $ -49.21M

LINEAGE CELL THERAPEUTICS INC's Op. Inc. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Op. Inc. Benchmarks
CompanyOp. Inc.
TVRD : TVARDI THERAPEUTICS INC $ -28.41MCRBU : CARIBOU BIOSCIENCES INC $ -169.96MSRZN : SURROZEN INC $ -27.89MPRTA : PROTHENA CORP PUBLIC LTD CO $ -281.61MFATE : FATE THERAPEUTICS INC $ -192.37MKRRO : KORRO BIO INC $ -98.55MCAPR : CAPRICOR THERAPEUTICS INC $ -73.41MTNXP : TONIX PHARMACEUTICALS HOLDING CORP $ -82.38MOCGN : OCUGEN INC $ -55.39MCRVO : CERVOMED INC $ -24.56M

Definition of Operating Income

[Income Statement] Operating income (income from operations) represents the gross profit [GP] less operating expenses [OpEx]. Operating income doesn’t include interest expenses [IntExp], tax expenses [TaxExp] and other Non-Operating items.

LCTX - Operating Income, Last 5 years

$ -49.21M

Minimum

Dec 31, 2021

$ -21.32M

Maximum

Mar 31, 2025

$ -29.54M

Average

$ -25.83M

Median

Op. Inc. Benchmark Analysis

The chart above depicts the distribution of Op. Inc. for companies in the Total Stock Market. The average Op. Inc. of the companies is $ 26.37M with a standard deviation of $ 130.87M.
The following table provides additional summary stats:
Op. Inc. in the Market:
filtered constituents3.32K
min$ -410.64M
max$ 444.54M
average$ 26.37M
median$ -903K
std$ 130.87M